Read our April issue!
This month we're exploring the impact of a #DEI ban on the #clinicalresearch ecosystem, tapping the #patientvoice as a strategic differentiator, the value of clinical trial liaisons in the #drugdevelopment lifecycle, and much more.
Not all FSP partnerships are built the same. This video breaks down how sponsors can weigh immediate staffing needs against a partner's ability to drive process improvement, innovation & long-term value.
https://t.co/zCHcwtOAx6
#AppliedClinicalTrials#FSP
The rules for global trial expansion have changed.
Patient availability alone won't protect enrolment timelines. Site readiness is now the difference between smooth execution and costly delays.
Register today: https://t.co/SPH4LNpOBD
Patients may be there, but is the site ready?
Global trial expansion isn't just about patient populations. Site capability, investigator experience, and operational readiness can determine whether enrolment succeeds or stalls.
Register now: https://t.co/wwy83TG1eD
Discover why modern research organizations are rethinking site technology to reduce burden, improve efficiency, and accelerate study execution. #ClinicalTrials
https://t.co/55Xt59H1lx
How could MRD negativity support accelerated approval in multiple myeloma?
Our upcoming panel explores the FDA’s January 2026 guidance, including trial design considerations, assay validation, and regulatory expectations for MRD-based programs.
Register: https://t.co/zlsW4IbC8P
The FDA has opened the door for MRD-based accelerated approval in multiple myeloma.
The question is: Are sponsors prepared?
Register today and gain insights to help navigate this evolving regulatory landscape: https://t.co/oHTDwLBZRu
Explore new ways to optimize clinical trials with real-world data, smarter recruitment, and decentralized strategies. Insights span the full trial lifecycle—from design to enrollment: https://t.co/hZg7unTGaz #ClinicalTrials
What comes after recruitment?
Andrelia Allen and Rebecca Johnson, PhD, of Merck discuss access, trust, and long-term community engagement in part three of this series.
🔗 Watch Part 3 now: https://t.co/oo4IJoxQrv
#AppliedClinicalTrials
How can the industry close the gap between access and trust in clinical trials?
In part two of this series, Andrelia Allen and Rebecca Johnson, PhD, of Merck share their perspectives.
🎥 Watch part two: https://t.co/UC3wKkhMFM
#AppliedClinicalTrials#ClinicalResearch
What makes social media worth your time?
Share your perspective and help shape the content you see on social media. Take the survey: https://t.co/TY1RIpR3Rp
#IndustryScienceOne#SocialMediaStrategy
How can the industry make clinical trial information more accessible?
In part one of this series, Andrelia Allen and Becky Johnson, PhD, of Merck discuss representation in clinical trial execution.
🎥 Watch part one: https://t.co/MN6SppNOB0
#AppliedClinicalTrials
Clinical trial recruitment delays are still slowing down progress for targeted therapies but there’s a better way forward.
Secure your spot and see how Quest can strengthen your recruitment mix.
Register today: https://t.co/i1DrGK85WT
Clinical Trials Day highlights the collaboration and innovation driving clinical research forward.
➡️ Explore insights on R&D success: https://t.co/tc7iL5Benz
➡️ Read industry perspectives on what Clinical Trials Day means: https://t.co/qJoatWqPV2
#ClinicalTrialsDay#ACT
Explore new ways to optimize clinical trials with real-world data, smarter recruitment, and decentralized strategies. Insights span the full trial lifecycle—from design to enrollment: https://t.co/AbMfvaE8Zh #ClinicalTrials
This webinar breaks down a smarter, data-driven approach to patient identification and outreach, showing how to improve precision, reduce cost, and accelerate timelines.
Save your spot: https://t.co/KlYi9903X3
Happening this week! Learn how RWD is being used alongside clinical trials to guide research, trial planning, regulatory strategy, and post-approval insights.
Register now: https://t.co/y1co5qAZgb
Empathy-driven tech is reshaping clinical trials—reducing burden, improving compliance, and strengthening patient-site relationships. See how digital tools are driving better outcomes: https://t.co/W6iqQzViNL #ClinicalTrials
Explore new ways to optimize clinical trials with real-world data, smarter recruitment, and decentralized strategies. Insights span the full trial lifecycle—from design to enrollment: https://t.co/glwblLaFkb #ClinicalTrials
Oncology treatment decisions are more complex than ever, spanning biomarkers, combination therapies, sequencing strategies, and longer patient journeys.
So where does real-world data fit in?
Find Out Here: https://t.co/GLUUyKrlv4